Immediate Impact

1 from Science/Nature 57 hit
Sub-graph 1 of 24

Citing Papers

Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis
2025 Hit
Hot and cold tumors: Immunological features and the therapeutic strategies
2023 Hit
2 intermediate papers

Works of A. L. Parke being referenced

Clinical Efficacy and Safety of Baminercept, a Lymphotoxin β Receptor Fusion Protein, in Primary Sjögren's Syndrome
2018

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
A. L. Parke 156 94 78 69 67 15 395
Yini Ke 94 0.6× 68 0.7× 61 0.8× 63 0.9× 31 0.5× 18 397
Jan Broekroelofs 68 0.4× 76 0.8× 178 2.3× 144 2.1× 39 0.6× 14 421
L Allegri 90 0.6× 126 1.3× 66 0.8× 57 0.8× 24 0.4× 24 438
I Pawlowski 48 0.3× 98 1.0× 106 1.4× 54 0.8× 85 1.3× 10 391
Maldonado Je 213 1.4× 108 1.1× 73 0.9× 52 0.8× 35 0.5× 15 409
Verônica Silva Vilela 247 1.6× 48 0.5× 36 0.5× 87 1.3× 25 0.4× 18 436
Steven Young‐Min 166 1.1× 65 0.7× 27 0.3× 54 0.8× 36 0.5× 16 390
Anwar Al‐Awadhi 68 0.4× 62 0.7× 31 0.4× 34 0.5× 37 0.6× 21 356
Cláudio Galperin 115 0.7× 56 0.6× 167 2.1× 61 0.9× 95 1.4× 12 372
H Gur 119 0.8× 74 0.8× 102 1.3× 44 0.6× 15 0.2× 20 353

All Works

Loading papers...

Rankless by CCL
2026